1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

MPN - 469

Clinical Profile, Molecular Landscape, and Outcomes of Myelofibrosis in Lebanon: Real-World Data

Hiba Smaily

Poster Presenter: Hiba Smaily

$Thumbnail for Clinical Trial vs Real-World Outcomes of BCMA- and GPRC5D-Targeted CAR-T, Bispecific Antibody, and ADC Therapies in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 903

Clinical Trial vs Real-World Outcomes of BCMA- and GPRC5D-Targeted CAR-T, Bispecific Antibody, and ADC Therapies in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Sai Sree Gummadi

Poster Presenter: Sai Sree Gummadi

SOHO 2026 Annual Meeting

Posters by Title

Clinical Profile, Molecular Landscape, and Outcomes of Myelofibrosis in Lebanon: Real-World Data

Clinical Trial vs Real-World Outcomes of BCMA- and GPRC5D-Targeted CAR-T, Bispecific Antibody, and ADC Therapies in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Clinically Relevant Subgroup Analysis From the Randomized Phase 3 EPCORE FL-1 Trial: Treatment (Tx) Effect of Epcoritamab (E) With Lenalidomide and Rituximab (R2) in Relapsed/Refractory Follicular Lymphoma (R/R FL)

Clinicodemographic Predictors of Outcome in Lymphoplasmacytic Lymphoma: Insights From a SEERStat Multivariate Model

Clinicopathological features, co-mutational patterns and outcomes in NPM1-mutated adult acute myeloid leukemia patients treated at Singapore General Hospital

Clonal Hematopoiesis Associated With Chronic Biomass-Smoke Exposure in Indigenous Tribal Populations of Maharashtra, India: A Pilot Molecular Screening Study

Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

Closing the Gap or Widening the Divide? Racial and Sex Disparities in Multiple Myeloma Mortality in the United States, 1999-2020

Co-Existing Myeloid Mutations at Diagnosis Are Associated With Increased Tyrosine Kinase Inhibitor Utilization in Chronic Phase CML